SynAct Pharma AB · OMXSTO:SYNACT
Quantass ApS sold 150,000 SynAct Pharma AB shares (MAR article 19 notification)
Traded Sep 2, 2026 · Filed Sep 7, 2026 · Read by 6ix Oct 14, 2026
On Sep 2, 2026, Quantass ApS (Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)) sold 150,000 SynAct Pharma AB shares at SEK 17.80 for SEK 2.67M. Filed Sep 7, 2026 (MAR article 19 notification).
- Sold
- 150,000 shares
- Price
- SEK 17.80
- Value
- SEK 2.67M
- Role
- Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)
The register entry
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SynAct Pharma AB | Sale | 150,000 | SEK 17.80 | Indirect |
Source
View original at Finansinspektionen
Related
- SynAct Pharma AB
- Quantass ApS
- SynAct Pharma AB shareholders
- MAR article 19 notification · Quantass ApS · Nov 18, 2026
- MAR article 19 notification · Quantass ApS · Mar 9, 2026
- MAR article 19 notification · Quantass ApS · Dec 22, 2025
- MAR article 19 notification · TJ Biotech Holding ApS · Sep 7, 2026
- MAR article 19 notification · Anders Kronborg · Mar 10, 2026
- MAR article 19 notification · Mads Liebach Bjerregaard · Mar 9, 2026
- MAR article 19 notification · Boesen Biotech ApS · Mar 6, 2026
- MAR article 19 notification · TJ Biotech Holding ApS · Dec 31, 2025